Peripheral clock disruption and metabolic disease: moving beyond the anatomy to a functional approach.
circadian
bmal1
clocks
endocrinology
metabolism
mouse models
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
03
2023
accepted:
09
05
2023
medline:
9
6
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
epublish
Résumé
Sleep and circadian disruption are associated with an increased risk of metabolic disease, including obesity and diabetes. Mounting evidence indicates that misaligned and/or non-functional clock proteins in peripheral tissues critically contribute to the presentation of metabolic disease. Many of the foundational studies which led to this conclusion have focused on specific tissues such as the adipose, pancreas, muscle, and liver. While these studies have greatly advanced the field, the use of anatomical markers to manipulate tissue-specific molecular clocks may not be representative of the circadian disruption that occurs within the clinical population. In this manuscript, we argue that investigators can gain a better understanding of the consequences of sleep and circadian disruption by targeting groups of cells with a functional relationship, even if those cells go beyond anatomical boundaries. This approach is especially important when considering metabolic outcomes which rely on endocrine signaling molecules, such as leptin, that have multiple sites of action. Through the review of several studies, as well as our own work, this article reframes peripheral clock disruption from a functional approach. We additionally present new evidence that disruption of the molecular clock within all cells expressing the leptin receptor affects leptin sensitivity in a time-dependent manner. Taken together, this perspective aims to provide new insight into the mechanisms leading to metabolic disease associated with circadian disruption and various sleep disorders.
Identifiants
pubmed: 37284222
doi: 10.3389/fendo.2023.1182506
pmc: PMC10241243
doi:
Substances chimiques
Leptin
0
CLOCK Proteins
EC 2.3.1.48
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1182506Informations de copyright
Copyright © 2023 Marino and Arble.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Methods Mol Biol. 2009;561:265-73
pubmed: 19504077
Curr Biol. 2013 Mar 4;23(5):372-81
pubmed: 23434278
Nat Med. 2012 Dec;18(12):1768-77
pubmed: 23142819
Endocrinology. 2011 Apr;152(4):1347-54
pubmed: 21285316
Obesity (Silver Spring). 2009 Nov;17(11):2100-2
pubmed: 19730426
Nutr Rev. 1998 Feb;56(2 Pt 2):s38-46; discussion s54-75
pubmed: 9564176
Science. 2005 May 13;308(5724):1043-5
pubmed: 15845877
Gastroenterology. 2002 May;122(5):1399-410
pubmed: 11984526
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4453-8
pubmed: 19255424
Diabetes. 2000 Apr;49(4):532-8
pubmed: 10871189
Behav Neural Biol. 1979 Mar;25(3):346-63
pubmed: 464979
Int J Mol Sci. 2020 Dec 09;21(24):
pubmed: 33316927
Hepatology. 2002 Apr;35(4):762-71
pubmed: 11915021
Science. 2000 Apr 28;288(5466):682-5
pubmed: 10784453
Obes Rev. 2012 Jun;13(6):528-36
pubmed: 22222118
Genes Dev. 2006 Jul 15;20(14):1868-73
pubmed: 16847346
Cell. 2000 Dec 22;103(7):1009-17
pubmed: 11163178
Genes Dev. 2000 Dec 1;14(23):2950-61
pubmed: 11114885
Genes Dev. 2017 Feb 15;31(4):383-398
pubmed: 28275001
Nat Rev Endocrinol. 2019 Jul;15(7):393-405
pubmed: 31073218
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15172-7
pubmed: 18779586
FEBS J. 2022 Nov;289(21):6589-6604
pubmed: 34657394
Skelet Muscle. 2016 Mar 30;6:12
pubmed: 27486508
Sleep. 2005 Apr;28(4):395-409
pubmed: 16171284
Nature. 2010 Jul 29;466(7306):627-31
pubmed: 20562852
Neurosci Lett. 2003 Jan 23;336(3):139-42
pubmed: 12505612
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3450-5
pubmed: 17360665
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33021965
Cell Metab. 2015 Sep 1;22(3):448-59
pubmed: 26166747
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5339-46
pubmed: 14963227
Endocrinology. 2015 Mar;156(3):1080-90
pubmed: 25521581
Cell Metab. 2007 Nov;6(5):414-21
pubmed: 17983587
Gastroenterology. 2009 Aug;137(2):713-23
pubmed: 19375424
Diabetes Metab Syndr Obes. 2019 Jan 25;12:191-198
pubmed: 30774404
J Mol Endocrinol. 2012 May 29;49(1):R9-17
pubmed: 22448029
Nat Sci Sleep. 2009 Dec 16;2:9-18
pubmed: 23616693
Chronobiol Int. 2018 Feb;35(2):198-207
pubmed: 29144185